Navigation Links
Former U.S. Surgeon General to Speak at Ross University School of Medicine's 2009 Graduation
Date:4/20/2009

Richard H. Carmona, M.D., M.P.H., F.A.C.S., will speak at Ross University School of Medicine's 2009 graduation ceremony at The Theater at Madison Square Garden.

North Brunswick, NJ (PRWEB) April 20, 2009 -- Ross University is pleased to announce that Richard H. Carmona, M.D., M.P.H., F.A.C.S., will speak at its 2009 graduation ceremony at The Theater at Madison Square Garden on Friday, June 5.

Born to a poor Hispanic family in New York City, Dr. Carmona was a high school dropout when he enlisted in the U.S. Army. He was trained as a Special Forces medic and weapons specialist and became a combat-decorated Vietnam veteran. After he returned to civilian life, Dr. Carmona earned a B.S. and M.D. from the University of California, San Francisco, where he was trained in general and vascular surgery and was awarded the prestigious gold-headed cane as the top graduate. In addition, Dr. Carmona completed a National Institutes of Health-sponsored fellowship in trauma, burns, and critical care; has been the medical director of police and fire departments; is a fully qualified peace officer and SWAT expert; is a Fellow of the American College of Surgeons; and started and directed Arizona's first regional trauma care system.

In 2002, Dr. Richard Carmona was nominated by President George W. Bush and unanimously confirmed by the United States Senate to become the 17th Surgeon General of the United States. Among many landmark communications issued during his four-year tenure, he released the definitive Surgeon General's Report about the dangers of secondhand smoke.

"We are honored that Dr. Carmona will speak at Ross' commencement," said Dr. Mary Coleman, dean of Ross University School of Medicine. "His remarkable achievements stand as an inspiration to us all."

In recognition of his outstanding contributions, Dr. Carmona is receiving an honorary Doct
'/>"/>

Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Page: 1 2

Related medicine news :

1. Statement by Joseph A. Califano, Jr., Chairman and President, The National Center on Addiction and Substance Abuse at Columbia University and Former U.S. Secretary of Health, Education and Welfare on New York States Action Council
2. Former Head of Office of Lilly CME, Steve Davidson, RPh, Named Medical Education Specialist at CME Enterprise
3. Former Executive at Genzyme Corp. and Osiris Therapeutics, Inc. to Head Business Advisory Board at Rx for Africa, Inc.
4. United States District Court Issues Temporary Restraining Order Against NUHW and Former Leaders of SEIU UHW; Court Orders Information and Property Belonging to SEIU UHW Members to Be Returned
5. Former MADD National President Joins Innocorp, ltd.
6. Innocorp, ltd. Hires Former MADD National President
7. New Coaching Program Helps Charge Nurses Develop Leadership Skills: B. E. Smith's Coaches Develop High Performers Who Improve Hospital Finances
8. Stem Cell Biotherapy Sues Casey Nabavi, Co-Founder and Former President, for Conduct Resulting in Claims by SCB Patients Against Nabavi, Embezzling Money and Converting Other Assets Belonging to SCB and for Wrongfully Establishing Cellulogix Biosciences t
9. A mothers criticism causes distinctive neural activity among formerly depressed
10. Former National Century Financial Enterprises CEO Sentenced to 30 Years in Prison, Co-owner Sentenced to 25 Years in Prison for Conspiracy, Fraud and Money Laundering
11. Endo Pharmaceuticals Solutions (Formerly Indevus Pharmaceuticals, Inc.) Announces Commencement of Offer to Purchase Its 6.25% Convertible Senior Notes Due 2009
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Former U.S. Surgeon General to Speak at Ross University School of Medicine's 2009 Graduation
(Date:5/26/2015)... New York (PRWEB) May 26, 2015 ... ( http://www.xareltolawsuit2015.com/ ) filed on behalf of individuals who ... for the litigation’s June 11th Science Day. According to ... District of Louisiana, on May 21st, topics to be ... the drug, the use of blood test based testing ...
(Date:5/26/2015)... 26, 2015 Now offering innovative, safe, ... center of Dr. Hedi Belajouza in Tunisia ... , Perfection to the last detail — meticulous hair ... location of the harvested follicle — are all results ... predominantly visible in the artistry and talent of Tunisian ...
(Date:5/26/2015)... San Francisco, CA (PRWEB) May 26, 2015 ... interested students to join them for the Open House/Free Application ... 11 a.m. and go until 4 p.m. and will be ... in San Francisco, CA. , After checking in, attendees will ... will then be a tour of the campus at 11:45 ...
(Date:5/26/2015)... (PRWEB) May 26, 2015 Marching ... the summer season, and thanks to the efforts ... solutions, more of their musicians are protecting their ... With over 400 participating groups, Etymotic’s Adopt-a-Band program ... by Etymotic are now for sale in drum ...
(Date:5/26/2015)... 3,000 senior industry executives are expected at the ... of the connected car. A very special attraction for ... read a driver’s brain waves. Visitors to its booth ... mind alone just by gripping the steering wheel! , ... working on cognitive load, altering music based on the ...
Breaking Medicine News(10 mins):Health News:Federal Xarelto Lawsuits Move Forward, as Court Establishes Procedures for Upcoming Science Day 2Health News:Federal Xarelto Lawsuits Move Forward, as Court Establishes Procedures for Upcoming Science Day 3Health News:Federal Xarelto Lawsuits Move Forward, as Court Establishes Procedures for Upcoming Science Day 4Health News:Hair Transplant Center in Tunisia Now Offering Innovative Restoration Technology 2Health News:Hair Transplant Center in Tunisia Now Offering Innovative Restoration Technology 3Health News:Hair Transplant Center in Tunisia Now Offering Innovative Restoration Technology 4Health News:ACTCM to Host Summer Open House 2Health News:Marching Musicians Getting In Step With Hearing Protection 2Health News:The World’s Biggest Connected Car Exhibition is Back in Detroit 2Health News:The World’s Biggest Connected Car Exhibition is Back in Detroit 3
... , , BIRMINGHAM, Ala., Sept. 21 ... that it has been awarded a $77.2 million contract modification by ... Phase 3 development of its influenza neuraminidase inhibitor, intravenous (i.v.) peramivir, ... "We are very excited to continue working with the ...
... , BOSTON, Sept. 21 SmarterTravel(R), a comprehensive ... for staying safe while traveling during this highly anticipated flu season. , ... Check your health insurance: Before you depart, ... case you develop the swine flu, or any illness, while traveling. , ...
... ... New England Office and Offers Assistance to 3 Local Companies , ... (Vocus) -- Omnion Consulting ... even subsisting, is offering 1 day (8 hours) of free strategic consulting to 3 ...
... collection of fluid around the heart, typically occurs in ... an invasive surgical drainage technique. However researchers have discovered ... is just as effective requiring no ... cost savings over the surgical drainage technique, according to ...
... , Second Annual Event Promotes Adaptive ... Sept. 20 Secretary of Veterans Affairs Eric K. Shinseki offered encouragement ... the 2nd National Veterans Summer Sports Clinic in San Diego. Calling ... kicked-off the clinic by telling his personal story of dealing with a ...
... toxic for some: study , SUNDAY, Sept. 20 ... women with advanced ovarian cancer, Japanese researchers say. ... weeks is considered standard first-line chemotherapy for advanced ... paclitaxel is seen as a way to increase ...
Cached Medicine News:Health News:BioCryst Awarded Additional $77.2 Million by the U.S. Department of Health & Human Services To Develop Peramivir for Influenza 2Health News:BioCryst Awarded Additional $77.2 Million by the U.S. Department of Health & Human Services To Develop Peramivir for Influenza 3Health News:BioCryst Awarded Additional $77.2 Million by the U.S. Department of Health & Human Services To Develop Peramivir for Influenza 4Health News:BioCryst Awarded Additional $77.2 Million by the U.S. Department of Health & Human Services To Develop Peramivir for Influenza 5Health News:Travel Precautions Critical During Swine Flu Season 2Health News:Travel Precautions Critical During Swine Flu Season 3Health News:New England Business Offers Free Service to Companies in Need 2Health News:Secretary Shinseki Kicks-Off National Sports Clinic 2Health News:New Chemo Regimen May Benefit Ovarian Cancer Patients 2
(Date:5/26/2015)... , May 26, 2015  AbbVie (NYSE: ... Phase 3 GIFT-I study of its investigational, all-oral, ... treatment with ombitasvir/paritaprevir/ritonavir at the Annual Meeting of ... Japan . 1 GIFT-I evaluated ... infected Japanese patients, with and without cirrhosis, who ...
(Date:5/26/2015)... -- Thoratec Corporation (NASDAQ: THOR ), a world ... and restore failing hearts, said today it will participate ... Conference on Tuesday, June 9. D. ... provide an update on the company, beginning at 2:00 ... The presentation will be available through the ...
(Date:5/26/2015)... , May 26, 2015  Amgen (NASDAQ: AMGN ... the Phase 3 OPTiM study in the Journal ... The data published in JCO , which were ... Society of Clinical Oncology (ASCO) in 2013 and 2014, ... patients with unresected stage IIIB, IIIC or IV metastatic ...
Breaking Medicine Technology:AbbVie Presents New Data for its Investigational Hepatitis C Treatment in Japanese Patients With and Without Cirrhosis 2AbbVie Presents New Data for its Investigational Hepatitis C Treatment in Japanese Patients With and Without Cirrhosis 3AbbVie Presents New Data for its Investigational Hepatitis C Treatment in Japanese Patients With and Without Cirrhosis 4AbbVie Presents New Data for its Investigational Hepatitis C Treatment in Japanese Patients With and Without Cirrhosis 5AbbVie Presents New Data for its Investigational Hepatitis C Treatment in Japanese Patients With and Without Cirrhosis 6Thoratec Presentation At Goldman Sachs Healthcare Conference To Be Webcast 2Pivotal Study Results Published in Journal of Clinical Oncology Showed Talimogene Laherparepvec Improved Durable Response Rates in Patients With Metastatic Melanoma 2Pivotal Study Results Published in Journal of Clinical Oncology Showed Talimogene Laherparepvec Improved Durable Response Rates in Patients With Metastatic Melanoma 3Pivotal Study Results Published in Journal of Clinical Oncology Showed Talimogene Laherparepvec Improved Durable Response Rates in Patients With Metastatic Melanoma 4Pivotal Study Results Published in Journal of Clinical Oncology Showed Talimogene Laherparepvec Improved Durable Response Rates in Patients With Metastatic Melanoma 5Pivotal Study Results Published in Journal of Clinical Oncology Showed Talimogene Laherparepvec Improved Durable Response Rates in Patients With Metastatic Melanoma 6Pivotal Study Results Published in Journal of Clinical Oncology Showed Talimogene Laherparepvec Improved Durable Response Rates in Patients With Metastatic Melanoma 7Pivotal Study Results Published in Journal of Clinical Oncology Showed Talimogene Laherparepvec Improved Durable Response Rates in Patients With Metastatic Melanoma 8
... and AMSTERDAM, August 10, 2011 Agendia, ... the 12th St. Gallen International Breast Cancer Conference (2011) ... - classifying patients by the particular biological subtype of ... cancer patients. According to the panel, "it is no ...
... is unpredictable and can be even more so when you ... sneezing or itchy, watery eyes just might earn you top ... Facebook.  Allergy sufferers are invited to upload a short video ... win $5,000 toward a fun-filled adventure where they can enjoy ...
Cached Medicine Technology:International St. Gallen Expert Panel Highlights Importance of Molecular Subtyping in Breast Cancer Treatment 2International St. Gallen Expert Panel Highlights Importance of Molecular Subtyping in Breast Cancer Treatment 3Allegra® and Survivor Winner Danni Boatwright Want to Hear About Your "Allergy Adventures" 2Allegra® and Survivor Winner Danni Boatwright Want to Hear About Your "Allergy Adventures" 3Allegra® and Survivor Winner Danni Boatwright Want to Hear About Your "Allergy Adventures" 4
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: